Noevir Holdings Co Ltd

Noevir Holdings Co Ltd maintains a strong liquidity position, with a current ratio of 4.44 and cash and equivalents amounting to ¥28.3 billion, significantly exceeding its total liabilities of ¥25.0 billion. The company's debt-to-equity ratio is 0.02, indicating a conservative capital structure with minimal reliance on long-term debt. This liquidity profile supports operational flexibility and reduces financial risk exposure.

The company's profitability metrics show a return on equity (ROE) of 3.75% and a return on assets (ROA) of 2.51%, which are below the typical thresholds for high-performing firms in the personal care industry. These figures suggest that Noevir is generating modest returns relative to its equity and asset base. Gross profit of ¥11.14 billion and operating income of ¥2.85 billion indicate a healthy gross margin, but the net income of ¥1.89 billion reflects the impact of operating expenses and taxes.

Noevir's revenue is concentrated in Japan, as disclosed in its business segments, with no material international operations reported. This geographic concentration exposes the company to local economic conditions and regulatory changes, which could affect its revenue stability. The company's product portfolio is focused on personal care, with no significant diversification into other consumer product categories.

The company's growth trajectory appears to be modest, with no significant revenue growth or decline reported in the latest financial data. Analysts have assigned a mean recommendation of 3.00, indicating a neutral outlook, with a single "hold" rating and no "buy" or "strong buy" ratings. The mean price target of ¥4,420.00 suggests limited upside potential in the near term.

Risk factors for Noevir include the potential for regulatory changes in the personal care industry, which could impact product formulations and marketing strategies. The company's low dilution risk is supported by the absence of immediate filing-based dilution flags and a stable share count. However, the company's reliance on a single geographic market and a narrow product portfolio increases its vulnerability to market-specific risks.

Recent events, including filings and transcripts, have not revealed any material changes in the company's operations or strategic direction. The company's capital expenditure of ¥745 million and free cash flow of ¥1.83 billion suggest a balanced approach to reinvestment and cash preservation.

Operating and net margins exceed the 75th percentile of the Personal Products cohort, indicating superior profitability relative to peers.

The company maintains a minimal debt-to-equity ratio of 0.02, significantly lower than the cohort median of 0.13.

Revenue grew at a 6.0% compound annual growth rate over the last four years, demonstrating consistent top-line expansion.

Cash conversion efficiency is rated best-in-class at 3.98, far surpassing the cohort median of 0.97.

Analysts project a 4.0% upside to a target price of 4,420 JPY, suggesting modest valuation support.

Revenue growth slowed significantly to just 1.4% year-over-year in FY2025, indicating weakening top-line momentum.

Return on equity stands at only 3.75%, which is merely above the cohort median rather than exceptional.

The single analyst recommendation is a 'hold', reflecting limited enthusiasm for near-term price appreciation.

Revenue ¥15.15B, −0,6% YoY; Operating income −13,0% YoY.

• ▍Revenue ¥15.15B, −0,6% YoY
• ▍Operating income −13,0% YoY
• ▍Net income −16,3% YoY
• ▍Net margin 9.2%

Revenue ¥15.47B, −8,0% YoY; Operating income −38,0% YoY.

• ▍Revenue ¥15.47B, −8,0% YoY
• ▍Operating income −38,0% YoY
• ▍Net income +35,8% YoY
• ▍Net margin 8.6%

Revenue ¥17.44B, +11,9% YoY; Operating income +27,4% YoY.

• ▍Revenue ¥17.44B, +11,9% YoY
• ▍Operating income +27,4% YoY
• ▍Net income +12,2% YoY
• ▍Free cash flow +1,8% YoY
• ▍Net margin 22.4%

Revenue ¥15.25B, −8,2% YoY; Operating income −19,4% YoY.

• ▍Revenue ¥15.25B, −8,2% YoY
• ▍Operating income −19,4% YoY
• ▍Net income −21,6% YoY
• ▍Free cash flow −11,5% YoY
• ▍Net margin 9.7%

Revenue ¥15.23B; Operating income ¥2.62B.

• ▍Revenue ¥15.23B
• ▍Operating income ¥2.62B
• ▍Net margin 10.9%

Revenue ¥16.80B; Operating income ¥3.17B.

• ▍Revenue ¥16.80B
• ▍Operating income ¥3.17B
• ▍Net margin 5.8%

Revenue ¥15.59B; Operating income ¥2.41B.

• ▍Revenue ¥15.59B
• ▍Operating income ¥2.41B
• ▍Net margin 22.3%

Revenue ¥16.61B; Operating income ¥2.85B.

• ▍Revenue ¥16.61B
• ▍Operating income ¥2.85B
• ▍Net margin 11.4%

Revenue ¥64.72B, +1,4% YoY; Operating income −2,3% YoY.

• ▍Revenue ¥64.72B, +1,4% YoY
• ▍Operating income −2,3% YoY
• ▍Net income +0,7% YoY
• ▍Free cash flow −302,6% YoY
• ▍Net margin 12.4%

Revenue ¥63.82B, +2,0% YoY; Operating income +3,6% YoY.

• ▍Revenue ¥63.82B, +2,0% YoY
• ▍Operating income +3,6% YoY
• ▍Net income +3,9% YoY
• ▍Free cash flow −11,7% YoY
• ▍Net margin 12.5%

Revenue ¥62.55B, +2,3% YoY; Operating income +2,4% YoY.

• ▍Revenue ¥62.55B, +2,3% YoY
• ▍Operating income +2,4% YoY
• ▍Net income +1,1% YoY
• ▍Free cash flow −51,7% YoY
• ▍Net margin 12.3%

Revenue ¥61.14B, +19,2% YoY; Operating income +26,4% YoY.

• ▍Revenue ¥61.14B, +19,2% YoY
• ▍Operating income +26,4% YoY
• ▍Net income +18,9% YoY
• ▍Free cash flow +155,7% YoY
• ▍Net margin 12.4%